Fractyl Health, Inc. (GUTS) Live Share Price, Invest From India

Fractyl Health, Inc. Stock Performance

as on October 25, 2025 at 1:29 am IST

Day's Low
Day's High
$1.36
Day's Price Range
$1.41
$1.38
1.45%
Downside
2.17%
Upside
52 Week's Low
52 Week's High
$0.83
52-Week Price Range
$3.48
$1.38
40.22%
Downside
152.25%
Upside

Fractyl Health, Inc. share price movements today

Previous Close: $1.38
Open: $1.40
Volume: 1.2M
Day's Low - High: $1.36 - $1.41
52 Week Low - High: $0.83 - $3.48

Fractyl Health, Inc. Historical Returns

1 Month Return: + 36.63 %
3 Month Return: -28.13 %
1 Year Return: -41.77 %
3 Year Return: 0 %
5 Year Return: 0 %

Fractyl Health, Inc. Stock Fundamentals & Key Indicators

Check Fractyl Health, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$182.4M

EPS (TTM)

-1.605

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-98.8M

Revenue (TTM)

17.0K

Profit Margin

0.00%

Return On Equity TTM

-379.75%

Fractyl Health, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fractyl Health, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Fractyl Health, Inc.	BUY	$182.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	251.51%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$109.3B	99.16%	30.04	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$62.0B	-0.32%	14.51	31.37%

Stock Returns calculator for Fractyl Health, Inc. Stock including INR - Dollar returns

The Fractyl Health, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Fractyl Health, Inc. investment value today

Current value as on today

₹62,834

Returns

₹37,166

(-37.17%)

Returns from Fractyl Health, Inc. Stock

₹41,772 (-41.77%)

Dollar Returns*

₹4,606 (+4.61%)

Analyst Recommendation on Fractyl Health, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Fractyl Health, Inc.. Average target price of $6.76

Fractyl Health, Inc. Share Price Target

Get share price movements and forecasts by analysts on Fractyl Health, Inc..

What analysts predicted

79.59%UPSIDE

Target Price

$6.76

Current Price

$1.38

Analyzed by

8 Analysts

Target

$6.76

Fractyl Health, Inc. target price $6.76, a slight upside of 79.59% compared to current price of $1.38. According to 8 analysts rating.

Fractyl Health, Inc. Stock’s Investor Sentiment and Interest

Search interest for Fractyl Health, Inc. Stock has increased by 1038% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 25, 2025 to October 25, 2025

Change:1038% versus previous 30 day period

Fractyl Health, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-12	-11	-13	-12	-21	-22	-23	-25	-24	-26
EBITDA	-11	-11	-13	-12	-21	-22	-23	-24	-24	-27
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-30	-15	-19	-3	-17	-23	-24	-23	-27
Income Tax Expense	-	0	-	-	-	-	-	-	-	-
Net Income	-11	-30	-15	-19	-3	-17	-23	-24	-23	-27
Net Profit Margin	-238640.00%	-41988.89%	-43741.67%	-274000.00%	-10066.67%	-40067.44%	-165521.43%	-832333.33%	0.00%	0.00%

Fractyl Health, Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Revenue	-	-	-	0	0
Gross Profit	0	0	0	0	0
Operating Income	-28	-36	-49	-50	-93
EBITDA	-28	-36	-48	-50	-92
Interest Expense	1	1	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-30	-38	-46	-77	-68
Income Tax Expense	-	-	-	-	-
Net Income	-30	-38	-46	-77	-68
Net Profit Margin	0.00%	0.00%	0.00%	-64242.50%	-73864.52%

Fractyl Health, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-30	-15	-19	-3	-17	-23	-24	-23	-27
Operating Cash Flow	-11	-11	-10	-11	-18	-18	-17	-25	-21
Investing Cash Flow	0	0	-	-1	0	0	0	0	0
Financing Cash Flow	0	27	0	101	0	0	0	0	1
Change in Cash	-11	16	-11	88	-19	-18	-17	-25	-19

Fractyl Health, Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Net Income	-30	-38	-46	-77	-68
Operating Cash Flow	-31	-33	-46	-42	-65
Investing Cash Flow	0	0	0	-	-1
Financing Cash Flow	54	99	4	27	101
Change in Cash	23	66	-46	-15	33

Insights on Fractyl Health, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, GUTS stock has moved up by 36.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 104.5%

About Fractyl Health, Inc.

Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Organisation	Fractyl Health, Inc.
Headquarters	3 Van de Graaff Drive, Burlington, MA, United States, 01803
CEO	Dr. Harith Rajagopalan M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Fractyl Health, Inc.

Name	Title
Mr. Brian Luque	Head of Investor Relations & Corporate Development
Ms. Sarah S. Toomey Esq.	General Counsel & Corporate Secretary
Ms. Jessica Cotrone	Vice President of Corporate Communications
Mr. Jon Fitzgerald	Senior Vice President of Regulatory, Quality & Clinical
Dr. Harith Rajagopalan M.D., Ph.D.	Co-Founder, CEO & Director
Mr. Jay D. Caplan BSEE, MBA	Co-Founder, Chief Product Officer & President
Ms. Lisa A. Davidson MBA	CFO & Treasurer

FAQs

What is Fractyl Health, Inc. share price today?

Fractyl Health, Inc. share price today is $1.38 as on October 25, 2025 at 1:29 am IST at the close of the market. Fractyl Health, Inc. share today touched a day high of $1.41 and a low of $1.36.

What is the 52 week high and 52 week low for Fractyl Health, Inc. share?

Fractyl Health, Inc. share touched a 52 week high of $3.48 on October 30, 2024 and a 52 week low of $0.83 on August 6, 2025. Fractyl Health, Inc. stock price today i.e. October 25, 2025 at 1:29 am IST is closed at $1.38,which is 60.36% down from its 52 week high and 67.27% up from its 52 week low.

What is Fractyl Health, Inc.'s market capitalisation today?

Fractyl Health, Inc. market capitalisation is $0.00T as on October 25, 2025 at 1:29 am IST.

How to invest in Fractyl Health, Inc. Stock (GUTS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fractyl Health, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fractyl Health, Inc. Shares that will get you 1.0870 shares as per Fractyl Health, Inc. share price of $1.38 per share as on October 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Fractyl Health, Inc. Stock (GUTS) from India?

Indian investors can start investing in Fractyl Health, Inc. (GUTS) shares with as little as ₹87.796 or $1 (as of October 25, 2025 at 5:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Fractyl Health, Inc. stock (as per the Rupee-Dollar exchange rate as on October 25, 2025 at 5:40 pm IST). Based on Fractyl Health, Inc. share’s latest price of $1.38 as on October 25, 2025 at 1:29 am IST, you will get 7.2464 shares of Fractyl Health, Inc.. Learn more about fractional shares .